Engy Shokry

Dr. Engy Shokry

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 February 2019 in Acta Diabetologica
Verified
Journal Article
Closed access
PDF file
ESEngy Shokry
Engy Shokry
LMLinda Marchioro
Linda Marchioro
OUOlaf Uhl
Olaf Uhl
MBMercedes G. Bermúdez
Mercedes G. Bermúdez
JSJOSÉ ANTONIO GARCÍA SANTOS
JOSÉ ANTONIO GARCÍA SANTOS
BKBerthold Koletzko
Berthold Koletzko

1 May 2015 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
ESEngy Shokry
Engy Shokry
FVFabio Villanelli
Fabio Villanelli
SMSabrina Malvagia
Sabrina Malvagia
ARAnna Rosati
Anna Rosati
GFGiulia Forni
Giulia Forni
GMGiancarlo La Marca
Giancarlo La Marca

24 March 2017 in Forensic Toxicology
Verified
Journal Article
Open access
PDF file
ESEngy Shokry
Engy Shokry
JMJair Gonzalez Marques
Jair Gonzalez Marques
PRPaulo César Ragazzo
Paulo César Ragazzo
NPNaiara Zedes Pereira
Naiara Zedes Pereira
NFNelson Roberto Antoniosi Filho
Nelson Roberto Antoniosi Filho
In this work, we presented, for the first time, earwax as an alternative forensic specimen for detecting 12 neuropsychotic drugs employing liquid chromatography–tandem mass spectrometry in positive and negative ion modes after straightforward extraction with methanol. The method was validated and standard curves were established by external calibration with correlation coefficients >0.99. All precision, accuracy, matrix effects, extraction recoveries, and carryover were within acceptable limits; limits of quantification were sufficiently low to quantify almost all the samples tested. To confirm the feasibility of the study, earwax specimens were collected from actual patients treated with different combinations of the 12 drugs and analyzed by our method; the 12 drugs could be quantified from the earwax specimens of the users successfully, showing usefulness of earwax specimens, because of its noninvasive sampling and the storage of drug(s) for relatively long time together with its being relatively less contaminated by environmental impurities. This study is pioneering; many detailed studies on earwax as an alternative specimen remain to be explored.

1 April 2017 in Journal of Proteomics
Verified
Journal Article
Closed access
ESEngy Shokry
Engy Shokry
AOAnselmo Elcana de Oliveira
Anselmo Elcana de Oliveira
MAMelissa Ameloti Gomes Avelino
Melissa Ameloti Gomes Avelino
MDMariana Moreira de Deus
Mariana Moreira de Deus
NFNelson Roberto Antoniosi Filho
Nelson Roberto Antoniosi Filho

15 October 2017 in Biochemia Medica
Verified
Journal Article
Open access
PDF file
ESEngy Shokry
Engy Shokry
NFNelson Roberto Antoniosi Filho
Nelson Roberto Antoniosi Filho
Insights into cerumen and application in diagnostics: past, present and future prospective

13 August 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
JBJoão Marcos Gonçalves Barbosa
João Marcos Gonçalves Barbosa
NPNaiara Zedes Pereira
Naiara Zedes Pereira
LDLurian Caetano David
Lurian Caetano David
COCamilla Gabriela de Oliveira
Camilla Gabriela de Oliveira
MSMarina Ferraz Gontijo Soares
Marina Ferraz Gontijo Soares
NFNelson Roberto Antoniosi Filho
Nelson Roberto Antoniosi Filho
Cancer is the deadliest human disease and the development of new diagnosis methods is important to increase the chances of a cure. In this work it was developed a new method, named here for the first time as cerumenogram, using cerumen (earwax) as a new biomatrix for diagnosis. Earwax samples collected from cancer patients (cancer group) and cancer-free patients (control group) were analyzed by Headspace/Gas Chromatography-Mass Spectrometry (HS/GC-MS), following with multivariate analysis steps to process the raw data generated. In total, 158 volatile organic metabolites (VOMs) were identified in the cerumen samples. The 27 selected as potential VOMs biomarkers for cancer provided 100% discrimination between the cancer and control groups. This new test can thus be routinely employed for cancer diagnoses that is non-invasive, fast, cheap, and highly accurate.